Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Trial of NanoPac Intratumoral Injection in Lung Cancer [Phase 2]
A Phase 2 trial of NanoPac intratumoral injection in lung cancer has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers [Phase 1, Phase 2]
A Phase 1/2 trial evaluating M7824 (bintrafusp alfa) in combination with Topotecan or Temozolomide for relapsed small cell lung cancer. The …
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]
The Phase 1/2 trial of surufatinib in combination with tislelizumab for advanced solid tumors has been terminated. Results were posted on 20…
-
CLINICAL_TRIALS trial_result · 2025-04-17Clinical Trial Update: A Study to Evaluate Subcutaneous Durvalumab in Patients With Non-Small Cell Lung Cancer and Small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating subcutaneous durvalumab for non-small cell lung cancer and small cell lung cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2025-04-16Clinical Trial Update: Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer [Phase 1, Phase 2]
Phase 1/2 study of endobronchial ultrasound-guided interstitial photodynamic therapy for locally advanced lung cancer was terminated, with r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Study of AZD2811 + Durvalumab in ES-SCLC [Phase 2]
A Phase 2 clinical trial evaluating the combination of AZD2811 and durvalumab for extensive-stage small cell lung cancer is active/not recru…
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China
This update reports the completion of a multicenter clinical trial evaluating sputum DNA testing for lung cancer in China, sponsored by Crea…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) [Phase 2]
A Phase 2 trial (QUADRUPLE THREAT) evaluated RRx-001 in small cell lung cancer, non-small cell lung cancer, neuroendocrine tumors, and epith…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Study of AK104 in Combination With Chiauranib in Patients With Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating AK104 in combination with Chiauranib for extensive-stage small cell lung cancer has completed; no specific resu…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC [Phase 2]
Updates on a Phase 2 study of PM8002 (anti-PD-L1/VEGF) in combination with chemotherapy for extensive-stage small cell lung cancer, with the…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of RO7616789 in advan…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors [Phase 2]
Phase 2 trial of ladiratuzumab vedotin in multiple advanced solid tumors was terminated, with results posted in March 2025.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer [Phase 3]
A Phase 3 trial evaluating platinum plus etoposide with or without tislelizumab in untreated extensive-stage small cell lung cancer has comp…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer [Phase 1]
Phase 1 study evaluating olaparib with low-dose radiotherapy for small cell lung cancer has completed. The trial investigates feasibility an…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers [Phase 1]
Phase 1 study of cosibelimab (CK-301) as a single-agent therapy in adults with advanced cancers; the trial status is active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating Olaparib plus Durvalumab in EGFR-mutated non-small cell lung cancer that transformed to small cell lung cancer an…
-
CLINICAL_TRIALS trial_result · 2025-01-16Clinical Trial Update: Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating toripalimab with platinum plus etoposide in extensive-stage small cell lung cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2025-01-07Clinical Trial Update: Durvalumab Plus Chemotherapy in Untreated Patients With Extensive-Stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating durvalumab plus chemotherapy in untreated extensive-stage small cell lung cancer has completed and posted results i…
-
CLINICAL_TRIALS trial_result · 2024-12-24Clinical Trial Update: INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer [EARLY_Phase 1]
This is an early Phase 1 clinical trial evaluating INK Cells as maintenance therapy after chemoradiotherapy in small cell lung cancer, with …
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC [Phase 2]
An update on a Phase 2 trial evaluating PM8002 in combination with chemotherapy for small cell lung cancer. The study, sponsored by Biotheus…
-
CLINICAL_TRIALS trial_result · 2024-12-09Clinical Trial Update: Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer [Phase 3]
Phase 3 clinical trial of Chiauranib Capsule for Small cell lung cancer has completed. The source does not provide results.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) [Phase 1]
The CLAMP Phase 1 trial evaluating chemotherapy with allopurinol and MycoPhenolate in relapsed small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: A Trial With Chemotherapy, Immunotherapy, and Radiotherapy for Patients With Newly Diagnosed Stage IV Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating a combination of chemotherapy, immunotherapy, and radiotherapy for newly diagnosed stage IV small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2024-11-19Clinical Trial Update: Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers [Phase 1, Phase 2]
Clinical trial update for Galinpepimut-S in combination with pembrolizumab in selected advanced cancers (Phase 1/2) with completed status an…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs [Phase 2]
Phase 2 randomized trial evaluating topotecan with the ATR inhibitor M6620 (VX-970) in small cell lung cancer and extrapulmonary small cell …